BrainSpec
Techstars '17Boston, US · Founded 2015 · Delaware corporation · 2 known investors
BrainSpec develops software for analyzing and visualizing MR spectroscopy (MRS) neuroimaging data, aiming to make a non-invasive "virtual biopsy" available to clinicians and researchers. Its technology targets patient populations with conditions such as brain tumors, Alzheimer's disease, and Multiple Sclerosis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Founders & leadership
AZ
Alexandra ZimmermanNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 round · 2017
▶$1.7MraisedSep 2017 · 6 investors · Other TechnologyRule 506(b)
▶$1.7MraisedSep 2017 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alexandra ZimmermanExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does BrainSpec do?
- BrainSpec develops software for analyzing and visualizing MR spectroscopy (MRS) neuroimaging data, aiming to make a non-invasive "virtual biopsy" available to clinicians and researchers. Its technology targets patient populations with conditions such as brain tumors, Alzheimer's disease, and Multiple Sclerosis.
- Who are BrainSpec's investors?
- BrainSpec's investors include Dorm Room, Techstars.
- How much funding has BrainSpec raised?
- BrainSpec has disclosed $1.7M raised across 1 round.
- Where is BrainSpec headquartered?
- BrainSpec is headquartered in Boston, US.